K. Cockerill

发表

Anti-beta2-glycoprotein I antibodies in complex with beta2-glycoprotein I can activate platelets in a dysregulated manner via glycoprotein Ib-IX-V.

G. M. Iverson, J. Rivera, M. Linnik, 2006, Arthritis and rheumatism.

Therapeutic Potential of Toleragens in the Management of Antiphospholipid Syndrome

G. M. Iverson, M. Linnik, K. Cockerill, 2012, BioDrugs.

In vivo characterization of bioconjugate B cell toleragens with specificity for autoantibodies in antiphospholipid syndrome.

Eric M. Smith, M. Hayag, M. Linnik, 2003, International immunopharmacology.

Domain V of β2-Glycoprotein I Binds Factor XI/XIa and Is Cleaved at Lys317-Thr318*

G. M. Iverson, M. Linnik, S. Krilis, 2005, Journal of Biological Chemistry.

Detection and characterization of B cell epitopes on β2-glycoprotein I

G. M. Iverson, M. Linnik, K. Cockerill, 2004 .

Multivalent poly(ethylene glycol)-containing conjugates for in vivo antibody suppression.

Eric M. Smith, J. Hammaker, H. Ton-nu, 2003, Bioconjugate chemistry.

Advances in understanding what we measure when detecting anticardiolipin autoantibodies.

G. M. Iverson, M. Linnik, E. J. Victoria, 2004, Clinica chimica acta; international journal of clinical chemistry.

Regulation of expression domains and effects of ectopic expression reveal gap gene-like properties of the linked pdm genes of Drosophila

S. Poole, A. Billin, Stephen J. Poole, 1993, Mechanisms of Development.

Isolation of a family of Drosophila POU domain genes expressed in early development

S. Poole, A. Billin, K. Cockerill, 1991, Mechanisms of Development.

Beta 2-Glycoprotein I binds factor XI and inhibits its activation by thrombin and factor XIIa: loss of inhibition by clipped beta 2-glycoprotein I.

G. M. Iverson, M. Linnik, S. Krilis, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Use of Single Point Mutations in Domain I of β2-Glycoprotein I to Determine Fine Antigenic Specificity of Antiphospholipid Autoantibodies1

G. M. Iverson, A. Sali, M. Martí-Renom, 2002, The Journal of Immunology.

Synthesis of LJP 993, a multivalent conjugate of the N-terminal domain of beta2GPI and suppression of an anti-beta2GPI immune response.

G. M. Iverson, D. S. Jones, M. Hayag, 2001, Bioconjugate chemistry.

Examining Manufacturing Readiness for Breakthrough Drug Development

John G. Groskoph, Kimberly M. L. May, G. Maheshwari, 2016, AAPS PharmSciTech.

The Orientation of β2GPI on the Plate is Important for the Binding of Anti-β2GPI Autoantibodies by ELISA

G. M. Iverson, E. Matsuura, M. Linnik, 2002 .

HT5 - FINDINGS FROM THE FIRST FIVE YEARS OF THE UK NICE HST PROGRAM

K. Cockerill, J. Gaebler, 2018, Value in Health.